MMRGlobal Shareholder Update on MMR Patent Litigation
LOS ANGELES, CA--(Marketwired - Jan 23, 2014) - MyMedicalRecords
Inc., a wholly owned subsidiary of MMRGlobal, Inc. (OTCQB: MMRF),
(collectively, "MMR"), today announced that based on court filings
dated January 21st 2014, MMR and Walgreen Co. are engaged in
continuing settlement discussions pertaining to a "potential
settlement or early resolution" to MMR's patent infringement
complaints pertaining to MMR's U.S. Patent No. 8,301,466 and U.S.
Patent No. 8,498,883 (the "883 Patent").
Walgreens and MMR filed a joint stipulation requesting an
extension of time for Walgreens to respond to MMR's complaint
involving MMR's '883 Patent, also referred to as United States
District Court, Central District of California Case No.:
CV-13-9214-ODW (SHx). The court filing states, amongst other
things, that:
"This Joint Stipulation Extending the Time to Respond to
Plaintiff's Complaint by Not More Than 30 Days is made and entered
into by and between Plaintiff MyMedicalRecords, Inc. ("MMR") and
Defendant Walgreen Co. ("Walgreens"), by and through their
respective counsel, with reference to the following facts:
A. Whereas, on January 2, 2014, Plaintiff served its
complaint on Walgreens. B. Whereas, the parties are continuing
discussions regarding a potential settlement or early resolution of
this matter. C. Whereas, the parties have agreed to extend
Walgreens' time to respond to the complaint by fourteen (14) days
to February 6, 2014."
Earlier this week, MMR announced that it is being awarded its
10th U.S. patent from the United States Patent and Trademark
Office, U.S. Patent No. 8,645,161 entitled "Method and System for
Providing Online Records." MMRGlobal is a practicing entity and a
leading provider of Personal Health Records ("PHRs") and MMRPro
document management and imaging systems for health care
professionals. This 10th and latest patent includes 30 claims
directed toward utilizing phones, wireless and other web-enabled
devices to allow for storing Personal Health Records in the form of
voice mail, faxes, email, HL7 and other media pertaining to the
receiving or sending of communications with health care providers,
pharmacies and other health care professionals. Subject matter
claimed also includes providing a user interface that collects and
displays prescriptions while helping submit them to pharmacies.
Additional claims allow users to annotate health records, and set
up appointment reminders with providers as well as medication
reminders through a built-in calendaring function, as well as the
collection and display of health insurance information. The 10th
patent adds to MMR's growing U.S. health IT patent portfolio which
also includes 18 pending U.S. applications in addition to issued
U.S. Patent Nos. 8,121,855; 8,117,045; 8,117,646; 8,301,466;
8,321,240; 8,352,287; 8,352,288; 8,498,883 and 8,626,532. The
MMR patent portfolio also includes numerous issued patents and
pending applications in other countries or regional authorities of
commercial interest including Australia, Singapore, New Zealand,
Mexico, Japan, Canada, China, Hong Kong, South Korea, Israel and
Europe.
Additional information can be found at:
http://phx.corporate-ir.net/phoenix.zhtml?c=178404&p=irol-irhome
About MMRGlobal MMRGlobal, Inc., through its wholly-owned
operating subsidiary, MyMedicalRecords, Inc., provides secure and
easy-to-use online Personal Health Records ("PHRs") and electronic
safe deposit box storage solutions, serving consumers, healthcare
professionals, employers, insurance companies, financial
institutions, retail pharmacies, and professional organizations and
affinity groups. The MyMedicalRecords PHR enables individuals and
families to access their medical records and other important
documents, such as birth certificates, passports, insurance
policies and wills, anytime from anywhere using the Internet.
MyMedicalRecords is built on proprietary, patented technologies to
allow documents, images and voicemail messages to be transmitted
and stored in the system using a variety of methods, including fax,
phone, or file upload without relying on any specific electronic
medical record platform to populate a user's account. MMR's
professional offering, MMRPro, is designed to give physicians'
offices an easy and cost-effective solution to digitizing
paper-based medical records and sharing them with patients through
an integrated patient portal. Through its merger with Favrille,
Inc. in January 2009, MMR acquired intellectual property biotech
assets that include anti-CD20 antibodies and data and samples from
its FavId™/Specifid™ vaccine clinical trials for the treatment of
B-Cell Non-Hodgkin's lymphoma. To learn more about MMRGlobal, Inc.
visit www.mmrglobal.com. View demos and video tutorials of MMR's
products and services at www.mmrtheater.com.
Forward-Looking Statements All statements in this press
release that are not strictly historical in nature, including,
without limitation, intellectual property enforcement actions,
infringement claims or litigation, intellectual property licenses,
and future performance, management's expectations, beliefs,
intentions, estimates or projections, constitute "forward-looking
statements." Such forward-looking statements involve known and
unknown risks, uncertainties and other factors that may cause MMR's
actual results to be materially different from historical results
or from any results expressed or implied by such forward-looking
statements. Some can be identified by the use of words (and their
derivations) such as "need," "possibility," "potential," "intend,"
"offer," "development," "if," "negotiate," "when," "begun,"
"believe," "achieve," "will," "estimate," "expect," "maintain,"
"plan," and "continue," or the negative of these words. Actual
outcomes and results of operations and the timing of selected
events may differ materially from the results predicted, and any
reported results should not be considered as an indication of
future performance. Such statements are necessarily based on
assumptions and estimates and are subject to various risks and
uncertainties, including those relating to the possible invalidity
of the underlying assumptions and estimates and possible changes or
developments in economic, business, industry, market, legal and
regulatory circumstances and conditions and actions taken or
omitted to be taken by third parties, including customers,
suppliers, business partners, potential licensees, competitors and
legislative, judicial and other governmental authorities and
officials. Factors that could cause or contribute to such
differences include, but are not limited to: unexpected outcomes
with respect to intellectual property enforcement actions, claims
of intellectual property infringement and general intellectual
property litigation; our ability to maintain, develop, monetize and
protect our patent portfolio for both MMR's health IT and
biotechnology intellectual property assets in the U.S. and
internationally; the timing of milestone payments in connection
with licensing our intellectual property; our ability to establish
and maintain strategic relationships; changes in our relationships
with our licensees; the risk MMR's products are not adopted or
viewed favorably by the healthcare community and consumer retail
market; business prospects, results of operations or financial
condition; risks related to the current uncertainty and instability
in financial and lending markets, including global economic
uncertainties; the timing and volume of sales and installations;
the length of sales cycles and the installation process; the
market's acceptance of new product and service introductions;
competitive product offerings and promotions; changes in government
laws and regulations including the 2009 HITECH Act and changes in
Meaningful Use and the 2010 Affordable Care Act; future changes in
tax legislation and initiatives in the healthcare industry;
undetected errors in our products; the possibility of interruption
at our data centers; risks related to third party vendors; risks
related to obtaining and integrating third-party licensed
technology; risks related to a security breach by third parties;
risks associated with recruitment and retention of key personnel;
other litigation matters; uncertainties associated with doing
business internationally across borders and territories; and
additional risks discussed in MMR's filings with the Securities and
Exchange Commission. MMR is providing this information as of
the date of this release and, except as required by applicable law,
does not undertake any obligation to update any forward-looking
statements contained in this release as a result of new
information, future events or otherwise.
CONTACT: Michael Selsman Public Communications Co.
ms@publiccommunications.biz (310) 922-7033